No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs139835341 |
chr11:25086621-25086622 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs192273627 |
chr11:25086625-25086626 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs1446163 |
chr11:25086653-25086654 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs564759099 |
chr11:25086661-25086662 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs1446162 |
chr11:25086664-25086665 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs116912762 |
chr11:25086677-25086678 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs372098129 |
chr11:25086680-25086681 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs563902861 |
chr11:25086684-25086685 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs529393500 |
chr11:25086753-25086754 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs549539629 |
chr11:25086762-25086763 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs1446161 |
chr11:25086768-25086769 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs183251792 |
chr11:25086810-25086811 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs551494901 |
chr11:25086811-25086812 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs571488802 |
chr11:25086815-25086816 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs562076736 |
chr11:25086828-25086829 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs556721260 |
chr11:25086832-25086833 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs577475182 |
chr11:25086864-25086865 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs371427325 |
chr11:25086870-25086871 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs187832832 |
chr11:25086902-25086903 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs552983659 |
chr11:25086917-25086918 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs538398660 |
chr11:25086918-25086919 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs544952935 |
chr11:25086919-25086920 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs558291969 |
chr11:25086941-25086942 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs7122480 |
chr11:25087004-25087005 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs544164023 |
chr11:25087017-25087018 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs145458676 |
chr11:25087030-25087031 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs144262639 |
chr11:25087042-25087043 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs148468156 |
chr11:25087050-25087051 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs77238145 |
chr11:25087060-25087061 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs142612814 |
chr11:25087064-25087065 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs1992732 |
chr11:25087092-25087093 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs527481868 |
chr11:25087096-25087097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs530705648 |
chr11:25087110-25087111 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs373447506 |
chr11:25087140-25087141 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs76666474 |
chr11:25087207-25087208 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs1992731 |
chr11:25087232-25087233 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs376787254 |
chr11:25087239-25087240 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs567224205 |
chr11:25087250-25087251 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs535999573 |
chr11:25087256-25087257 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs143457538 |
chr11:25087264-25087265 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs546045927 |
chr11:25087269-25087270 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs374245733 |
chr11:25087276-25087277 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs566535519 |
chr11:25087277-25087278 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs538386286 |
chr11:25087285-25087286 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs564810345 |
chr11:25087350-25087351 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs112265617 |
chr11:25087381-25087382 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs575355125 |
chr11:25087405-25087406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs537738000 |
chr11:25087411-25087412 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs549421171 |
chr11:25087441-25087442 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs146669280 |
chr11:25087442-25087443 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|